PubMed

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, Rich S, Barst RJ, Barrett PS, Kral KM, Jöbsis MM, Loyd JE, Murali S, Frost A, Girgis R, Bourge RC, Ralph DD, Elliott CG, Hill NS, Langleben D, Schilz RJ, McLaughlin VV, Robbins IM, Groves BM, Shapiro S, Medsger TA Jr.

Ann Intern Med. 2000 Mar 21;132(6):425-34.PMID: 10733441 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group.

Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, et al.

N Engl J Med. 1996 Feb 1;334(5):296-302.PMID: 8532025 [PubMed - indexed for MEDLINE]Related articlesFree article

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.

Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost AE, Engel PJ, Kramer MR, Burgess G, Collings L, Cossons N, Sitbon O, Badesch DB; PACES Study Group.

Ann Intern Med. 2008 Oct 21;149(8):521-30. Erratum in: Ann Intern Med. 2009 Jan 6;150(1):63. Ann Intern Med. 2009 Sep 15;151(6):435. PMID: 18936500 [PubMed - indexed for MEDLINE]Related articlesFree article

Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.

Oudiz RJ, Schilz RJ, Barst RJ, Galié N, Rich S, Rubin LJ, Simonneau G; Treprostinil Study Group.

Chest. 2004 Aug;126(2):420-7.PMID: 15302727 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.

Galiè N, Humbert M, Vachiéry JL, Vizza CD, Kneussl M, Manes A, Sitbon O, Torbicki A, Delcroix M, Naeije R, Hoeper M, Chaouat A, Morand S, Besse B, Simonneau G; Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group.

J Am Coll Cardiol. 2002 May 1;39(9):1496-502.PMID: 11985913 [PubMed - indexed for MEDLINE]Related articles

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.

Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS.

Ann Intern Med. 1994 Sep 15;121(6):409-15.PMID: 8053614 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.

Rubin LJ, Mendoza J, Hood M, McGoon M, Barst R, Williams WB, Diehl JH, Crow J, Long W.

Ann Intern Med. 1990 Apr 1;112(7):485-91.PMID: 2107780 [PubMed - indexed for MEDLINE]Related articles

Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series.

McLaughlin VV, Genthner DE, Panella MM, Hess DM, Rich S.

Ann Intern Med. 1999 May 4;130(9):740-3.PMID: 10357693 [PubMed - indexed for MEDLINE]Related articlesFree article

[Long-term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic]

Jansa P, Ambroz D, Maresová J, Jelínková L, Polácek P, Palecek T, Aschermann M, Linhart A.

Vnitr Lek. 2007 Apr;53(4):333-7. Czech. PMID: 17578162 [PubMed - indexed for MEDLINE]Related articles

Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.

Cabrol S, Souza R, Jais X, Fadel E, Ali RH, Humbert M, Dartevelle P, Simonneau G, Sitbon O.

J Heart Lung Transplant. 2007 Apr;26(4):357-62.PMID: 17403477 [PubMed - indexed for MEDLINE]Related articles

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.

Olschewski H, Ghofrani HA, Schmehl T, Winkler J, Wilkens H, Höper MM, Behr J, Kleber FX, Seeger W.

Ann Intern Med. 2000 Mar 21;132(6):435-43.PMID: 10733442 [PubMed - indexed for MEDLINE]Related articlesFree article

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, Oudiz R, Frost A, Blackburn SD, Crow JW, Rubin LJ; Treprostinil Study Group.

Am J Respir Crit Care Med. 2002 Mar 15;165(6):800-4.PMID: 11897647 [PubMed - indexed for MEDLINE]Related articlesFree article

Beraprost therapy for pulmonary arterial hypertension.

Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, Rubin L, Wasserman K, Oudiz R, Shapiro S, Robbins IM, Channick R, Badesch D, Rayburn BK, Flinchbaugh R, Sigman J, Arneson C, Jeffs R; Beraprost Study Group.

J Am Coll Cardiol. 2003 Jun 18;41(12):2119-25. Erratum in: J Am Coll Cardiol. 2003 Aug 6;42(3):591. PMID: 12821234 [PubMed - indexed for MEDLINE]Related articles

Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.

Humbert M, Sanchez O, Fartoukh M, Jagot JL, Le Gall C, Sitbon O, Parent F, Simonneau G.

Eur Respir J. 1999 Jun;13(6):1351-6.PMID: 10445611 [PubMed - indexed for MEDLINE]Related articlesFree article

Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.

Gomberg-Maitland M, Tapson VF, Benza RL, McLaughlin VV, Krichman A, Widlitz AC, Barst RJ.

Am J Respir Crit Care Med. 2005 Dec 15;172(12):1586-9. Epub 2005 Sep 8.PMID: 16151039 [PubMed - indexed for MEDLINE]Related articlesFree article

Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension.

Tapson VF, McLaughlin VV, Gomberg-Maitland M, Widlitz AC, Krichman AD, Laliberte KJ, Zaccardelli DS, Barst RJ.

J Vasc Access. 2006 Jul-Sep;7(3):112-7.PMID: 17019662 [PubMed - indexed for MEDLINE]Related articles

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.

Tapson VF, Gomberg-Maitland M, McLaughlin VV, Benza RL, Widlitz AC, Krichman A, Barst RJ.

Chest. 2006 Mar;129(3):683-8.PMID: 16537868 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ.

Lancet. 2001 Oct 6;358(9288):1119-23.PMID: 11597664 [PubMed - indexed for MEDLINE]Related articles

Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.

Benza RL, Rayburn BK, Tallaj JA, Pamboukian SV, Bourge RC.

Chest. 2008 Jul;134(1):139-45. Epub 2008 Apr 10.PMID: 18403673 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Hervé P, Rainisio M, Simonneau G.

J Am Coll Cardiol. 2002 Aug 21;40(4):780-8.PMID: 12204511 [PubMed - indexed for MEDLINE]Related articles